JB PHARMA CELEBRATES 1 YEAR OF ITS NEW IDENTITY LAUNCH June 5, 2023 7:14 amNews Updateadmin00 SHARE Records revenue growth of 22% to INR 762 crores in Q4 FY23 & grew 30% to INR 3149 crores in FY23 & operating EBITDA increased by 21% to INR 181 crores in Q4 FY23 A year of market-beating growth, superior performance & an optimistic outlook towards READ MORE POST TAGS: cardiologygastroenterologyGynaecologyHealthhealthcarehealthcare IndustryJB PHARMAMr. Nikhil Choprapharmaceuticalpharmacieswell-being